WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

SYSTEMATIC REVIEW OF PORPHYRIA

Akhila P.*, Sreethu P. and Bincy Vargheese

ABSTRACT

The porphyrias are a group of rare diseases in which chemical substances called porphyrins accumulate with high metabolism. The body requires porphyrins to produce heme, which carries oxygen in the blood. But in the porphyrias, there is a deficiency (inherited or acquired) of the enzymes that transform the various porphyrins into others, leading to abnormally high levels of one or more of these substances. This manifests with neurological symptoms or skin problems, or both. Porphyrias are classified in two ways, by symptoms and by pathophysiology. Symptomatically, acute porphriyas cause brain and nerve involvement, often with severe abdominal pain, vomiting, neuropathy, and mental disturbances. Coetaneous porphyrias cause skin problems, often exposure to sunlight, because porphyries react with light. Physiologically, porphyrias are classified as hepatic or erythropoietic based on the sites of accumulation of heme precursors, either in the liver or in the bone marrow and red blood cells. Administer the hematin infusions to treat the acute attacks in patients with the acute hepatic porphyrias, and perform the bone marrow or hematopoietic stem cell transplants therapies for congenital erythropoietic protoporphyria. These developments are reviewed to update the latest advances in these diverse disorders.

Keywords: Porphyria, Coetaneous porphyrias, erythropoietic porphyrias.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More